Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial

Michael T Lu1, Maros Ferencik2, Rhonda S Roberts3

  • 1Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Insights

Noninvasive fractional flow reserve derived from computed tomography (FFRCT) better predicts cardiac events than coronary computed tomography angiography (CTA) stenosis. Adding FFRCT can improve the efficiency of invasive coronary angiography referrals.

Area of Science:

  • Cardiovascular Imaging
  • Medical Diagnostics
  • Interventional Cardiology

Background:

  • Coronary computed tomography angiography (CTA) provides anatomic information but has limitations in predicting functional significance of coronary stenosis.
  • Stable chest pain is a common indication for non-invasive cardiac imaging and subsequent invasive procedures.
  • Fractional flow reserve derived from computed tomography (FFRCT) offers a noninvasive method to assess the functional impact of coronary artery disease.

Purpose of the Study:

  • To evaluate if FFRCT predicts coronary revascularization and adverse cardiac events in patients with stable chest pain.
  • To determine if incorporating FFRCT enhances the efficiency of referral to invasive coronary angiography (ICA) after CTA.
  • To compare the predictive value of FFRCT against traditional CTA stenosis assessment.

Main Methods:

  • An observational cohort study of patients from the PROMISE trial with stable chest pain referred for ICA post-CTA.
  • FFRCT was calculated by a blinded core laboratory; results were not available to clinicians.
  • Agreement between FFRCT and stenosis on CTA/ICA was assessed, along with predictive value for revascularization or major adverse cardiac events (MACE).

Main Results:

  • FFRCT was calculated in 67% of eligible patients; it was discordant with CTA and ICA stenosis in 31% and 29% of cases, respectively.
  • An FFRCT threshold of ≤0.80 was a significantly better predictor of revascularization or MACE compared to severe CTA stenosis (HR 4.3 vs. 2.9).
  • Utilizing FFRCT ≤0.80 as a gatekeeper could reduce unnecessary ICAs by 44% and increase revascularization rates by 24%.

Conclusions:

  • FFRCT ≤0.80 is a superior predictor of revascularization or MACE than severe stenosis on CTA in patients with stable chest pain.
  • Integrating FFRCT into the diagnostic pathway following CTA has the potential to optimize referral patterns for invasive coronary angiography.
  • This approach may improve the efficiency and yield of invasive coronary angiography in the evaluation of coronary artery disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...